By Bette Flagler
Monday 1st December 2003 |
Text too small? |
Launched on 14 October at the annual conference of the New Zealand Grassland Association, Grasslanz has evolved from the Cultivar Development and Management Unit (CDMU) and will carry on with the development and commercialisation of plant technologies, including endophytes and plant cultivars of rye grass, white clover and tall fescue. Stewart says that with only eight employees, Grasslanz is a small company that can take products to market faster than, for instance, a big concern like AgResearch. He also sees the new business arrangement - one step further away from government - as a positive move for taking on outside business partners, stating that, "the company can't develop more products on its current revenue. The future biotechnologies are very exciting stuff, and we will be looking to grow the business through expansion in domestic and international markets, technology and business partnerships. Grasslanz has a strong hold in Australasia on the pasture seed business, and has the capacity to deliver that throughout the world. It's very exciting for big companies like Monsanto, who controls 90% of the transgenics, to find a seed company like Grasslanz."
Stewart is excited about the state of biotechnology in New Zealand in general and is looking to drive the company into diversifications that can be applicable across many species. The board of Grasslanz is expected to be named by the end of November. Celentis has nine other subsidiaries, including AgVax Development, Bio Products, Time Capsule, ComOne and Covita.
No comments yet
PaySauce Quarterly Market Update - September 2024
October 2nd Morning Report
Rua Releases Annual Report for Year Ended 30 June 2024
SCL - Settlement of orchard sales
The Warehouse Group 2024 ASM and Director Nominations
AIR - Update on Chief Operational Integrity and Safety Officer
Comvita Limited - Annual Report 2024
September 27th Morning Report
Spark announces departure of Finance Director
FBU - Retail Entitlement Offer Opens